Human ovarian cancer and cisplatin resistance: Possible role of inhibitor of apoptosis proteins

Endocrinology

Volumn 142, Issue 1, 2001, Pages 370-380

  Li, Julang ^a,b   Feng, Qiang ^a,b   Kim, Jong Min ^a,b   Schneiderman, Danielle ^a,b   Liston, Peter ^d   Li, Ming ^a,b   Vanderhyden, Barbara ^a,e   Faught, Wylam ^a,c   Fung, Michael Fung Kee ^a,c   Senterman, Mary ^a,c   Korneluk, Robert G ^d   Tsang, Benjamin K ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d Apoptogen Inc   (Canada)

^e OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHEMOSENSITIVITY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAMMAL CELL; MULTIDRUG RESISTANCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TUMOR GROWTH;

EID: 17744379360     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7897     Document Type: Article

References (48)

1. Chemotherapy-induced apoptosis in epithelial ovarian cancer
2. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells
3. Structural aspects of platinum anticancer drug interaction with DNA
4. Mechanisms and function of cell death
5. Mechanisms and genes of cellular suicide
6. Apoptosis in the pathogenesis and treatment of disease
7. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas
8. The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and bcl-2
9. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma
10. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
11. Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators
12. An apoptosis inhibiting gene from a nuclear polyhedrosis virus encoding a peptide with Cys/His sequence motifs
13. An apoptosis-inhibiting baculovirus gene with a zing finger-like motif
14. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy
15. Suppression of apoptosis in mammalian cells by Naip and a related family
16. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors
17. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors
18. The TNFR2-TRAF signalling complex contains two novel proteins related to baculovirus inhibitor of apoptosis proteins
19. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
20. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and sensitive human ovarian carcinoma cell lines by buthomine sulfoximine mediated glutathione depletion
21. Mechanisms of resistance to cisplatin and alkylating agents
22. Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine
23. Cell cycle changes associated with formation of P-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity
24. Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line
25. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines
26. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues
27. Mitrochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells
28. Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells
29. Down-regulation of XIAP induces apoptosis in chemoresistant human ovarian cancer cells
30. A simple method for preparing suspension of luteal cells
31. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome
32. Expression of apoptosis inhibitory proteins (IAPs) in rat granulosa cells during follicular development and atresia
33. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation I
34. Apoptosis: Its significance in cancer and cancer therapy
35. Bcl-2 and the regulation of programmed cell death
36. X-linked IAP is a direct inhibitor of cell-death proteases
37. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
38. Prostaglandins mediate the stimulation of deoxyribonucleic acid synthesis by transforming growth factor α in hen granulosa cells during ovarian follicular development
39. Transforming growth factor α inhibits apoptosis in hen granulosa cells
40. Induction of apoptosis and inhibition of proliferation by survivin
41. Adducts of the antitumor drug cis-diammmedichloroplatinum (II) with DNA: Formation, identification and quantitation
42. Reevaluation of interaction of cis-dechloro(ethylenediamine) platinum (II) with DNA
43. 2 phase and cell and cell death induced by cisplatin
44. Activation of programmed cell death by cisplatin, other anti-cancer drugs, toxins and hyperthermia
45. Bcl-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
46. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines
47. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell system
48. Drug-target interactions: Only the first step in the commitment to a programmed cell death?